Massimo Cristofanilli, M.D.

Call
Website
1283 York Ave
New York, NY 10065
+1 (646) 962-2330
https://weillcornell.org
Massimo Cristofanilli, MD, is an accomplished board-certified medical oncologist with more than two decades of experience as physician, investigator, researcher and leader. He has demonstrated original and innovative vision in the field of molecular diagnostics, liquid biopsy, translational research and drug development. Additionally, Dr. Cristofanilli has an extensive background in clinical trial design and is a key thought leader in the field of metastatic and locally advanced breast cancer.At Weill Cornell Medicine and NewYork-Presbyterian, Dr. Cristofanilli serves as the Director of Breast Medical Oncology, the Associate Director of Precision Oncology at the Meyer Cancer Center (MCC), and the co-leader of the MCC Breast Cancer Disease Management Team, as well as the Scientific Director of the Englander Institute of Precision Medicine (EIPM).Dr. Cristofanilli received his medical degree from the University "La Sapienza" in Rome with Honors where he subsequently completed his fellowship in medical oncology. He completed an Internal Medicine residency at Cabrini Medical Center in New York and a medical oncology fellowship at The University of Texas MD Anderson Cancer Center, where he also served as Faculty in the Department of Breast Medical Oncology for more than a decade.Dr. Cristofanilli has held several leadership positions over the years, including Chair of Medical Oncology and Associate Director of Clinical Research at the Fox Chase Cancer Center and Associate Director of Translational Research at Thomas Jefferson University. From 2015-2021, Dr. Cristofanilli was Professor of Medicine at the Robert H. Lurie Comprehensive Cancer Center at Northwestern University in Chicago where he also served as the Director of the Breast Disease Team, Director of the Robert Lurie Cancer Center OncoSET Precision Medicine Program, and Associate Director of Clinical Research.In addition to his clinical expertise, Dr. Cristofanilli's research focuses on biomarkers of endocrine resistance in breast cancer, liquid biopsies and novel drug development. His research in the areas of novel drug development, circulating tumor cells (CTCs) and ctDNA have led to improved treatments for breast cancer. Dr. Cristofanilli is an internationally recognized expert in the research and treatment of Inflammatory Breast Cancer (IBC), the most aggressive and deadly form of breast cancer. He is the founder and President of the IBC International Consortium (IBC-IC). Additionally, Dr. Cristofanilli is globally recognized for his contributions on the detection of micrometastatic disease in breast cancer and a key opinion leader in drug development in hormone-receptor positive metastatic breast cancer. He has co-authored more than 400 peer-reviewed manuscripts.

Also at this address

Own this business?
See a problem?

You might also like

John Robert Ferrarone, M.D.
Internal medicine practitioners

John Robert Ferrarone, M.D.

Dr. Ferrarone graduated medical school from New York Medical College. He completed both his residency in internal medicine and his fellowship in medical oncology at Weill Cornell Medicine and NewYork-Presbyterian Hospital. After his fellowship, Dr. Ferrarone received training in cancer biology research under the guidance of the Nobel laureate Dr. Harold Varmus. Dr. Ferrarone’s clinical and research efforts are focused on lung cancer. In his laboratory, he studies how mutations in certain genes influence the growth of tumors and their interaction with the immune system. The aim of his research is to provide new insights into the behavior of lung cancer, to enable the development of new cancer treatments and the rational design of clinical trials.
John Ng, M.D.
Internal medicine practitioners, Psychiatrists and psychoanalysts, Services, nec, nec

John Ng, M.D.

John Ng, M.D. is a Board Certified Radiation Oncologist and Assistant Professor of Radiation Oncology at Weill Cornell Medical College/New York Presbyterian Hospital. As a native New Yorker, he received his undergraduate degree in Physics at Columbia University. He went to medical school at Harvard and also received a Master of Science degree in Biophysics from Harvard University. He received his M.D. degree from Harvard Medical School, jointly with the Massachusetts Institute of Technology, as part of the Health Sciences and Technology (HST) program. He returned to New York City and the Columbia University Medical Center for his residency training in Radiation Oncology, where he also served as a chief resident. He joined the Weill Cornell Medical Center as faculty, where he serves as attending physician for Breast Oncology and for Gastrointestinal Oncology. His most recent awards include the Faculty Educator of the Year Award from the Weill Cornell New York-Presbyterian Residency Program, a RSNA Roentgen Research Award, an ASCO Research Travel Award, and a NCCN Travel Grant.Dr. Ng was recently appointed the Chair of the Radiation Oncology Section of New York Roentgen Society, the only scientific group that congregates radiation oncologists in the New York Metropolitan area and is comprised of leaders in the fields of diagnostic radiology and radiation oncology. He also currently serves as a Program Committee member for the American Association for Cancer Research (AACR), serves on the Economics Committee of the American College of Radiation Oncology (ACRO), and is an active Program Committee member of the New York Metropolitan Breast Cancer Group.Areas of Specialization:Breast Cancer, Gastrointestinal Cancers, Breast Intraoperative Radiotherapy, Breast Balloon Brachytherapy, Pancreatic Cancer, Sarcoma, Stereotactic Body Radiotherapy (SBRT).Research:Dr. Ng’s research is focused on developing novel radiation techniques that can reduce treatment side effects and improve outcomes. One area of particular focus is developing partial breast radiotherapy techniques to treat less breast tissue with less radiation to reduce side effects and to shorten treatment times.Another research interest is advancing radiotherapy technologies to treat pancreatic cancer. He is currently writing a textbook review on Gastrointestinal and Hepatobiliary Radiation Therapy and working on a review on minimizing malignancy risks after radiation therapy.He is also actively involved in the development of new drugs and agents to use with radiotherapy to improve cure rates for breast cancer and gastrointestinal cancers. Presently, his group is collaborating with others in developing skin products to decrease skin side effects from breast radiotherapy.

Alan B. Astrow, M.D.

United States›New York›New York›Massimo Cristofanilli, M.D.

Partial Data by Foursquare.